Inner Mongolia Grand Pharmaceutical Co (BJSE:836433) ROCE % : 1.03% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Inner Mongolia Grand Pharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Inner Mongolia Grand Pharmaceutical Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 1.03%.

Inner Mongolia Grand Pharmaceutical Co ROCE % Historical Data

The historical data trend for Inner Mongolia Grand Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inner Mongolia Grand Pharmaceutical Co ROCE % Chart

Inner Mongolia Grand Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

25.59

17.65

13.42

4.05

2.61

Inner Mongolia Grand Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															6.65	14.28	-8.21	-2.35	1.03

Inner Mongolia Grand Pharmaceutical Co ROCE % Calculation

Inner Mongolia Grand Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	12.943	/	( ( (646.206 - 156.749)	+	(740.258 - 237.902) )	/ 2 )
	=	12.943	/	( (489.457	+	502.356)	/ 2 )
	=	12.943	/	495.9065
	=	2.61 %

Inner Mongolia Grand Pharmaceutical Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	5.188	/	( ( (740.258 - 237.902)	+	(678.67 - 174.414) )	/ 2 )
	=	5.188	/	( ( 502.356	+	504.256 )	/ 2 )
	=	5.188	/	503.306
	=	1.03 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Inner Mongolia Grand Pharmaceutical Co (BJSE:836433) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Inner Mongolia Grand Pharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Inner Mongolia Grand Pharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Inner Mongolia Grand Pharmaceutical Co (BJSE:836433) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Inner Mongolia Grand Pharmaceutical Co Ltd (BJSE:836433) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

Wuwei Road, 2nd Floor, Administration Building, Ruyi Development Zone, Inner Mongolia Autonomous Region, Hohhot, CHN, 010010

Website

http://www.nmdt.com.cn

Inner Mongolia Grand Pharmaceutical Co Ltd is a pharmaceutical enterprise integrating the development of Mongolian medicine resources. It engages in the research and development, production and sales of special specialty medicines and general health products. The company's main business is the research and development and production of Chinese patent medicines (including ethnic medicines) and chemical preparations and sales.

Inner Mongolia Grand Pharmaceutical Co (BJSE:836433) Headlines

No Headlines